MRNA

195.0002.17%
FN

Francois Nader

Independent Non Executive Director

Dr. Francois Nader, M.D., MBA, is Chairman of the Board of GEn1E Lifesciences Inc. He was Director of Ring Therapeutics, Inc. from March 2022. He serves as Independent Chair of the Board at Tectonic Therapeutic, Inc. since April 1, 2026. He serves as Director at Valera LLC. He serves as Senior Advisor at Blackstone Life Sciences. He serves as Independent Non-Executive Director at Moderna, Inc., since December 2019. He served as Director at Tourmaline Bio, Inc. He served as the Non-Executive Chairman of Prevail Therapeutics Inc. since April 2019 until January 21, 2021. Dr. Nader serves as the Independent Chairman of Talaris Therapeutics, Inc. since November 2018. Dr. Nader is the Founder of Jesra Advisors, LLC and served as its Chief Executive Officer since February 2015. He served as Director of Prevail Therapeutics Inc., since May 2018 until January 21, 2021. He serves as Member of Advisory Council at SVB Securities LLC. He serves as Chairman at Benevolent AI and Neurvati Biosciences, as Board Director of Moderna. Dr. Nader served as the President, Chief Executive Officer and Executive Director of NPS Pharmaceuticals, Inc. or NPS from March 17, 2008 to February 21, 2015. Dr. Nader served as Chief Commercial Officer and Chief Medical Officer of NPS Pharmaceuticals, Inc. from June 06, 2006 to July 03, 2007 and served as its Chief Operating Officer from July 03, 2007 to March 2008. Dr. Nader joined NPS in 2006 and served as Executive Vice President until 2008. He also served at Sanofi. Prior to NPS, Dr. Nader served as a Venture Partner of Care Capital, LLC and served as the Chief Medical Officer of Clinical Development Capital Unit from July 2005 to June 2006. He served as Senior Vice President and Head of Global Commercial Operations of Pasteur Vaccines Division at Sanofi US Services Inc. He served as Senior Vice President and Head of Global Commercial Operations of Pasteur Vaccines Division at Aventis S.A. He served on the North America Leadership Team of Aventis S.A. and its predecessor companies holding a number of executive positions including Senior Vice President of Integrated Healthcare Markets and North America Medical and Regulatory Affairs with Aventis Pharmaceuticals from 2000 to 2004. He also held similar positions at Hoechst Marion Roussel. Dr. Nader is a recognized leader in industry and philanthropic organizations. He served as Vice President of Hoechst Marion Roussel Inc. Dr. Nader had been the Chairman of Acceleron Pharma Inc. since March 2015 and had been its Director since December 2014. He has been advisor for SVB-Leerink. He served as the Chairman of BioNJ Inc. Dr. Nader was an Independent Non-Executive Director of Advanced Accelerator Applications. Inc., S. A., since May 26, 2016 until January 22, 2018. He had been an Independent Director of Alexion Pharmaceuticals, Inc. since November 08, 2017 until July 21, 2021. He served as Independent Non-Executive Director of ArRETT Neurosciences from 2016 to 2019. He had been a Director of Clementia Pharmaceuticals, Inc. since February 2014 until 2019. He has served on the boards of the Biotechnology Industry Organization (BIO). He served as a Director of NPS Pharmaceuticals, Inc. from January 2008 to February 21, 2015. He served as a Director of Baxalta Incorporated from July 27, 2015 to June 03, 2016. He served as a Director of Trevena, Inc. from January 08, 2014 to June 30, 2015. He served as a Director of Noven Pharmaceuticals, Inc. since May 22, 2009. He served as Director of BioNJ Inc. until February 9, 2017. Dr. Nader serves as the President of the Jesra Foundation, a Trustee/ Board Member of the New Jersey Chamber of Commerce and sits on the Advisory Board of the Open Future Institute. He recognized as the Ernst and Young National Life Science Entrepreneur of the in 2013. He studied M.D. (French Doctorate in Medicine) from St. Joseph University (Lebanon) in 1981. He holds his Physician Executive MBA from the University of Tennessee in 2000.

Positions